China Journal of Leprosy and Skin Diseases ›› 2021, Vol. 37 ›› Issue (8): 543-548.doi: 10.12144/zgmfskin202108543

• Reviews • Previous Articles     Next Articles

Update of the treatment of invasive aspergillosis

WANG Shuangshuang1,2, HU Xiaoping2, YU Bo2   

  1. 1 Shantou University Medical College, Shantou 515041, China; 2 Department of Dermatology,Shenzhen Hospital of Peking University, Shenzhen 518036, China
  • Online:2021-08-15 Published:2021-07-21
  • Contact: YU Bo, E-mail: yubomd@163.com

Abstract: Invasive aspergillosis (IA) is a serious deep fungal infection caused by Aspergillus  fungi. In recent years, the incidence of IA is increasing year by year with the widespread use of immunosuppressants and broad-spectrum antibiotics, the widespread development of invasive diagnosis and treatment such as organ transplantation, and the increasing number of patients with malignant tumors and acquired immunodeficiency syndrome. The high mortality rate of IA patients is still a serious threat to their lives and health. The update of the treatment of invasive aspergillosis is reviewed in this paper.

Key words: invasive aspergillosis, antifungal drugs, treatment